세계의 단백질체학 시장은 CAGR 9.42%를 나타내 2025년 367억 2,000만 달러에서 2030년에는 575억 8,200만 달러로 성장할 것으로 예측됩니다.
단백질체학 시장은 생물학적 과정에서 단백질과 그 역할에 대한 연구의 중요성이 증가함에 따라 큰 성장을 이루고 있습니다. Proteomics는 생물체의 단백질 데이터 세트에 대한 종합적인 연구로, 세포 간 및 시간에 따라 변화하는 단백질의 구조, 기능 및 상호 작용을 다룹니다. 이 분야는 단백질의 상호작용, 국재, 생물학적 프로세스에의 관여에 관한 중요한 인사이트을 제공하며, 의학·생물학 연구의 발전에 필수적이 되고 있습니다. 이 시장은 기술의 진보와 맞춤형 의료에 대한 수요 증가에 추진되고 있지만, 고비용이나 숙련 전문가의 부족 등의 과제가 성장의 방해가 될 가능성이 있습니다. 이러한 과제에도 불구하고, 특히 의료 인프라가 정비되어 연구 자금이 윤택한 지역에서는 시장의 확대가 전망되고 있습니다.
주요 촉진요인
기술 진보
LC/MS, GC/MS, FT-MS, MALDI-TOF/TOF 등의 듀얼 질량 분석기를 포함한 질량 분석(MS)과 같은 기술의 진보는 단백질체학 시장의 주요 촉진요인입니다. 이러한 혁신을 통해 단백질 구조의 상세한 해석이 가능해져 1개의 겔로 수천 유형의 단백질을 분리·해석할 수 있습니다. 단백질 분획 기술과 바이오인포매틱스의 향상은 복잡한 프로테옴 데이터를 처리하는 능력을 더욱 강화하고 연구 및 임상 응용 분야에서의 채용을 촉진합니다. 연구개발에 대한 투자 증가도 최첨단 단백질체학 툴의 개발을 가속화하고 시장 성장을 지원합니다.
맞춤형 의료에 대한 수요 증가
개별 환자프로파일에 맞게 치료를 실시하는 맞춤형 의료에 대한 주목 증가가 단백질체학 수요를 밀어 올리고 있습니다. 단백질체학는 단백질의 발현이나 상호작용에 관한 지견을 제공함으로써 특히 암 등의 질환에 대한 표적요법의 개발을 가능하게 합니다. 이 수요는 바이오마커 및 치료 표적을 식별하기 위한 단백질체학 연구에 대한 자금 제공 증가에 의해 더욱 지원되고 있으며, 의료 시스템이 정밀의료를 선호하는 가운데 시장 확대를 이끌고 있습니다.
The global proteomics market is expected to grow from USD 36.720 billion in 2025 to USD 57.582 billion in 2030, at a CAGR of 9.42%.
The global proteomics market is experiencing significant growth, driven by the increasing importance of studying proteins and their roles in biological processes. Proteomics, the comprehensive study of an organism's protein dataset, encompasses their structure, functions, and interactions, which vary across cells and over time. This field provides critical insights into protein interactions, localization, and involvement in biological processes, making it essential for advancing medical and biological research. The market is propelled by technological advancements and rising demand for personalized medicine, though challenges such as high costs and a shortage of skilled professionals may hinder growth. Despite these obstacles, the market is poised for expansion, particularly in regions with advanced healthcare infrastructure and strong research funding.
Key Growth Drivers
Technological Advancements
Advancements in technologies such as mass spectrometry (MS), including dual mass analyzers like LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF, are major drivers of the proteomics market. These innovations enable detailed analysis of protein structures, allowing thousands of proteins to be resolved in a single gel. Improvements in protein fractionation techniques and bioinformatics further enhance the ability to process complex proteomic data, driving adoption in research and clinical applications. Increased investments in research and development are also accelerating the development of cutting-edge proteomic tools, supporting market growth.
Rising Demand for Personalized Medicine
The growing focus on personalized medicine, which tailors treatments to individual patient profiles, is boosting demand for proteomics. By providing insights into protein expression and interactions, proteomics enables the development of targeted therapies, particularly for diseases like cancer. This demand is further supported by increased funding for proteomic research, which aims to identify biomarkers and therapeutic targets, driving market expansion as healthcare systems prioritize precision medicine.
Market Segmentation
By Geography
The proteomics market is segmented into North America, South America, Europe, the Middle East and Africa, and Asia-Pacific. North America is expected to hold a significant market share, driven by its rapid adoption of advanced technologies and robust healthcare infrastructure. The region's focus on personalized medicine and substantial investments in research further support market growth. Asia-Pacific is projected to be the fastest-growing region, fueled by rising government funding for proteomics research and increasing interest in precision medicine in countries like China and India, where healthcare systems are expanding rapidly.
Competitive Landscape
Key players, including Proteomics International, Biognosys AG, and Creative Proteomics (a division of Creative Dynamics Inc.), are driving innovation in the proteomics market. These companies focus on developing advanced proteomic technologies and services, enhancing data analysis capabilities, and supporting applications in personalized medicine and biological research, strengthening their market positions.
The global proteomics market is set for robust growth, propelled by advancements in technologies like mass spectrometry and the rising demand for personalized medicine. North America leads due to its advanced infrastructure and research investments, while Asia-Pacific's rapid growth reflects increased funding and healthcare advancements. Despite challenges like high costs and a lack of skilled professionals, the market's trajectory remains positive, driven by the critical role of proteomics in understanding biological processes and developing targeted therapies, supported by ongoing innovation from leading industry players.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Segmentation: